Yiangos Psaras and Rupen Hargreaves have been selected as the 2023 Fellows; Christopher Toepfer and Susie Shapiro are the RDM Principal Investigators on the projects, with this being the first time they have been awarded this opportunity.
The Oxford–BMS Fellowship Programme supports postdoctoral fellows carrying out cutting-edge three-year translational projects. Since its establishment in 2015, the programme has supported 37 Fellowships that aim to stimulate new scientific discovery and translation, and generate a cohort of scientists that can navigate within and across academic and industry spheres to bridge translational challenges.
BMS scientists will provide the researchers with critical scientific input to the translational projects, along with mentorship and exposure to the field of commercial drug discovery and development. There will also be opportunities to carry out research and use facilities at BMS labs in the US and Spain.
Read more on the Medical Sciences Division website.